Crossref journal-article
Elsevier BV
Journal of Controlled Release (78)
Bibliography

Rafati, H., Coombes, A. G. A., Adler, J., Holland, J., & Davis, S. S. (1997). Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. Journal of Controlled Release, 43(1), 89–102.

Authors 5
  1. H Rafati (first)
  2. A.G.A Coombes (additional)
  3. J Adler (additional)
  4. J Holland (additional)
  5. S.S Davis (additional)
References 31 Referenced 171
  1. R.G. Tice and D.R. Cowsar, Biodegradable controlled-release parenteral systems. Pharm. Tech. 8 (1984) 26–35.
  2. R. Langer, New methods of drug delivery. Science 249 (1990) 1527–1533. (10.1126/science.2218494)
  3. D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers. In: M. Chassin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1–41.
  4. W. Morris, M.C. Steinhoff and P.K. Russell, Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 12 (1994) 5–11. (10.1016/0264-410X(94)90003-5)
  5. D.T. O'Hagan, Oral delivery of vaccines. Clin. Pharmacokinet. 22 (1992) 1–10. (10.2165/00003088-199222010-00001)
  6. D.T. O'Hagan, H. Jeffery and S.S. Davis, Long term antibody response in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 11 (1993) 965–969. (10.1016/0264-410X(93)90387-D)
  7. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley and T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microparticles target the Peyer's patches. J. Control. Release 11 (1990) 205–214. (10.1016/0168-3659(90)90133-E)
  8. J. P. McGee, J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa and H. Kiyono, The mucosal immune systems: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75–87. (10.1016/0264-410X(92)90021-B)
  9. D.T. O'Hagan, J.P. McGee, M. Lindblad and J. Holmgren, Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization. Int. J. Pharm. 119 (1995) 251–255. (10.1016/0378-5173(95)00046-L)
  10. T. Uchida and S.H. Goto, Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. Biol. Pharm. Bull. 17 (1994) 1272–1276. (10.1248/bpb.17.1272)
  11. P.U. Jani, A.T. Florence and D.E. McCarthy, Further histological evidence of the gasterointestinal absorption of polystyrene nanospheres in rat. Int. J. Pharm. 84 (1992) 245–252. (10.1016/0378-5173(92)90162-U)
  12. P.G. Jenkins, K.A. Howard, N.W. Blackhall, N.W. Thomas, S.S. Davis and D.T. O'Hagan, Microparticulate absorption from the rat intestine. J. Control. Release 29 (1994) 339–350. (10.1016/0168-3659(94)90079-5)
  13. R. Jalil and J.R. Nixon, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsul. 7 (1990) 297–325. (10.3109/02652049009021842)
  14. R. Arshady, Preparation of biodegradable microparticles and microcapsules. 2. Polylactide and related polyesters. J. Control. Release 17 (1991) 1–22. (10.1016/0168-3659(91)90126-X)
  15. Y. Ogawa, M. Yamomoto, H. Okada, T.T. Yashiko and T. Shimamoto, A new technique to efficiently entrap Leuprolide acetate into microcapsules of copoly lactic/glycolic acid. Chem. Pharm. Bull. 36 (1988) 1095–1103. (10.1248/cpb.36.1095)
  16. M.N. Vrancken and D.A. Claeys, U.S. Patent 3526906, 1970.
  17. H. Jeffery, S.S. Davis and D.T. O'Hagan, The preparation and characterisation of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in oil-in water) emulsion solvent evaporation technique. Pharm. Res. 10 (1993) 362–368. (10.1023/A:1018980020506)
  18. S. Cohen, T. Yoshioka, M. Lucarelli, H.L. Hwang and R. Langer, Controlled delivery systems for protein based on poly(lactic/glycolic acid) microparticles. Pharm. Res. 8 (1991) 713–720. (10.1023/A:1015841715384)
  19. M.J.B. Prieto, F. Delie, E. Fattal, A. Tartar, F. Puisieux, A. Gulik and P. Couvreur, Characterisation of V3BRU peptide-loaded small PLGA microparticles prepared by a (W1/O)W2 emulsion solvent evaporation method. Int. J. Pharm. 111 (1994) 137–145. (10.1016/0378-5173(94)00104-9)
  20. C. Yan, J.H. Resau, J. Heweston, M. West, W.L. Rill and M. Kende, Characterisation and morphological analysis of protein loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J. Control. Release 32 (1994) 231–241. (10.1016/0168-3659(94)90233-X)
  21. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice and R.M. Gilley, Release of human serum albumin from poly(lactide-co-glycolide) microparticles. Pharm. Res. 7 (1990) 1190–1194. (10.1023/A:1015948829632)
  22. B. Alberts, B. Dennis, L. Julian, M. Raff, K. Roberts and J.D. Watson, Molecular Biology of Cells, Garland Publishing, New York.
  23. N. Nihant, C. Schugens, C. Grandfils, R. Jerome and P. Teyssie, Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11 (1994) 1479–1484. (10.1023/A:1018912426983)
  24. G. Crotts and T.G. Park, Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J. Control. Release 35 (1995) 91–105. (10.1016/0168-3659(95)00010-6)
  25. H. K. Sah, R. Toddywala and Y.W. Chien, The influence of biodegradable microcapsules formulation on the controlled release of a protein. J. Control. Release 30 (1994) 201–211. (10.1016/0168-3659(94)90026-4)
  26. H.T. Wang, E. Schmitt, D.R. Flanagan and R.J. Linhardt, Influence of formulation methods on the in vivo controlled release of protein from poly(ester) microparticles. J. Control. Release 17 (1991) 23–32. (10.1016/0168-3659(91)90127-Y)
  27. A.G.A. Coombes, E.C. Lavelle, P.G. Jenkins and S.S. Davis, Surface dose polymeric microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine (1996) in press. (10.1016/S0264-410X(96)00077-1)
  28. L. Tang and J.W. Eaton, Mechanism of acute inflammatory response to biomaterials. Cells Mater. 4 (1994) 429–436.
  29. R. Arshady, Microparticles and microcapsules. A survey of manufacturing techniques. Part III. Solvent evaporation. Polym. Eng. Sci. 30 (1990) 915–921. (10.1002/pen.760301506)
  30. R. Bodmeier and J.W. McGinity, Solvent selection in the preparation of poly(dl-lactide) microparticles prepared by the solvent evaporation method. Int. J. Pharm. 43 (1988) 179–186. (10.1016/0378-5173(88)90073-7)
  31. P.D. Scholes, A.G.A. Coombes, L. Illum, S.S. Davis and M.C. Davies, The preparation of sub-150 nm poly(lactide-co-glycolide) microparticles for site specific drug delivery. J. Control. Release 25 (1993) 145–153. (10.1016/0168-3659(93)90103-C)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 8:12 a.m.)
Deposited 6 years, 4 months ago (April 26, 2019, 1 a.m.)
Indexed 1 month ago (Aug. 2, 2025, 1:05 a.m.)
Issued 28 years, 8 months ago (Jan. 1, 1997)
Published 28 years, 8 months ago (Jan. 1, 1997)
Published Print 28 years, 8 months ago (Jan. 1, 1997)
Funders 0

None

@article{Rafati_1997, title={Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics}, volume={43}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/s0168-3659(96)01475-7}, DOI={10.1016/s0168-3659(96)01475-7}, number={1}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Rafati, H and Coombes, A.G.A and Adler, J and Holland, J and Davis, S.S}, year={1997}, month=jan, pages={89–102} }